Insiders Gilead Sciences, Inc.

Equities

GILD

US3755581036

Pharmaceuticals

Market Closed - Nasdaq Other stock markets 21:00:00 05/06/2026 BST			5-day change	1st Jan Change
129.16 ^USD	-0.02%		-3.92%	+5.23%

06-05	The Jobs Report Just Made the Fed's Life Harder
06-05	Keymed Biosciences Receives $257 Million Upfront Payment After Gilead-Ouro Deal Close	MT

Insiders

06-03	Gilead Sciences Insider Sold Shares Worth $1,971,847, According to a Recent SEC Filing	MT
05-18	Gilead Sciences Insider Sold Shares Worth $3,676,199, According to a Recent SEC Filing	MT
04-29	Gilead Sciences Insider Sold Shares Worth $1,291,608, According to a Recent SEC Filing	MT
04-08	Gilead to Buy Cancer Biotech Tubulis in $5B Deal	MT
03-17	PFL President on Sports Betting, Partnerships, MMA Rise	MT
03-02	Gilead Sciences Insider Sold Shares Worth $1,447,859, According to a Recent SEC Filing	MT
02-18	Gilead Sciences Insider Sold Shares Worth $4,324,228, According to a Recent SEC Filing	MT
02-18	Gilead Sciences Insider Sold Shares Worth $463,290, According to a Recent SEC Filing	MT
01-29	Gilead Sciences Insider Sold Shares Worth $1,398,911, According to a Recent SEC Filing	MT
01-27	Gilead Sciences Insider Sold Shares Worth $15,611,400, According to a Recent SEC Filing	MT
01-21	Gilead Sciences Insider Sold Shares Worth $617,500, According to a Recent SEC Filing	MT
12-18	Gilead Sciences, Inc. Appoints Keeley Wettan as Executive Vice President, General Counsel, Legal & Compliance Effective December 18, 2025	CI
11-19	Gilead says Deborah Telman to step down as evp at Gilead Sciences - SEC filing	RE
11-19	Deborah H. Telman to No Longer Serve as Executive Vice President, Corporate Affairs and General Counsel of Gilead Sciences, Inc. as of December 5, 2025	CI
11-19	Gilead Sciences Insider Sold Shares Worth $3,524,173, According to a Recent SEC Filing	MT
11-14	Gilead Sciences Insider Sold Shares Worth $6,590,487, According to a Recent SEC Filing	MT
29/10/25	Gilead Sciences Insider Sold Shares Worth $1,193,926, According to a Recent SEC Filing	MT
30/09/25	Gilead Sciences Insider Sold Shares Worth $1,116,564, According to a Recent SEC Filing	MT
16/09/25	Gilead Sciences Insider Sold Shares Worth $340,710, According to a Recent SEC Filing	MT
16/09/25	Gilead Sciences Insider Sold Shares Worth $283,925, According to a Recent SEC Filing	MT
29/08/25	Gilead Sciences Insider Sold Shares Worth $1,136,300, According to a Recent SEC Filing	MT
19/08/25	Gilead Sciences Insider Sold Shares Worth $3,318,927, According to a Recent SEC Filing	MT
14/08/25	Gilead Sciences, Inc. Announces Management Changes, Effective September 22, 2025	CI
16/07/25	Gilead Sciences Insider Sold Shares Worth $277,575, According to a Recent SEC Filing	MT
15/07/25	Gilead Sciences Insider Sold Shares Worth $548,700, According to a Recent SEC Filing	MT